Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine adjuvant to caudal bupivacaine for hypospadias repair
NCT02618876Completed
- Sponsor
- Assiut University
- Start
- Nov 2015
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of nalbuphine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Face, Legs, Activity, Cry & consolability pain scale at 24 hours. Started Nov 2015; status: completed.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02618876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02618876.